Chronic pain costs more than heart disease, cancer and diabetes combined yet gets a fraction of their funding. Judy Foreman knows well the cost of our medical systems dysfunctional approach to pain. A medical journalist used to good medical care, she was dismayed by...
Ampligen became the first drug ever approved for use in ME/CFS when ANMAT, Argentine’s FDA, approved the drug for use in severe ME/CFS patients. The approval should provide a clear pathway for Ampligen’s approval elsewhere. The U.S. is the odd man out in...
Infection Fells Teenager In August 2014, a formerly very healthy and active Jack Schlanger entered the realm of the chronically ill. The thirteen-year-old’s story began with three days of high fever followed by eight days of lower-grade fever and extreme...
This has a been good week for advocacy. It’s showing that smart advocacy works. Twice advocates went straight back into “the system” looking for results and twice – once with the PACE trial and here with AHRQ report in the U.S. – they...
If you live in the U.S. where drugs typically cost 2-6 times more than elsewhere, drug bills can really add up. Buying drugs from international pharmacies can save U.S. consumers a lot of money – but is it safe? Health Rising takes a look in that issue in Buying...
Please support Health Rising in our Quickie Summer Donation Drive! Our goal is $15,000.Click here for more.
Stay Up to Date with ME/CFS, Long COVID and Fibromyalgia News
Get Health Rising's free blogs featuring the latest findings and treatment options for the ME/CFS, long COVID, fibromyalgia and complex chronic disease communities.